Autoimmune Thyroid Disease and Female Fertility: Clinical Evidence on Ovarian Reserve, Infertility Treatment Outcomes, and Pathophysiology
Reproductive Medicine and Biology · 2026-01 · 25 (1)
DOI: 10.1002/rmb2.70052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 15.04.2026. Verfasst von Akira Iwase und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology Gunma University Graduate School of Medicine Maebashi Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Thyroid autoimmunity (TAI) is prevalent among women of reproductive age and has been associated with impaired fertility; however, its effects on ovarian reserve and infertility treatment outcomes remain controversial.
Methods
A narrative review was performed using PubMed to identify clinical and experimental studies addressing TAI, ovarian reserve, premature ovarian insufficiency (POI), and infertility treatment outcomes.
Results
Clinical evidence suggests that TAI is associated with modestly reduced AMH levels in adult women, although the magnitude of this decline appears insufficient to indicate imminent POI. In contrast, adolescents with TAI may exhibit elevated AMH. Observational studies describe a frequent coexistence of TAI and POI; however, Mendelian randomization analyses suggest that POI may predispose to TAI rather than the reverse. Mechanistic studies show that thyroid hormones act directly on ovarian cells via thyroid hormone receptors, while immune‐mediated pathways involving cytokines, oxidative stress, and anti‐ovarian antibodies may contribute to follicular dysfunction. Evidence regarding assisted reproductive technology outcomes in euthyroid TAI remains inconsistent.
Conclusion
TAI may exert a subtle influence on ovarian reserve through complex endocrine and immune mechanisms, with age‐specific variation. Although AMH alterations are observed, their clinical relevance for fertility and treatment outcomes remains unclear, highlighting the need for longitudinal studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology Gunma University Graduate School of Medicine Maebashi Japan.
- Department of Obstetrics and Gynecology Jichi Medical University Tochigi Japan.
- Department of Obstetrics and Gynecology Akita University Graduate School of Medicine Akita Japan.
- Women's Medical Center, Takagi Hospital/Department of Obstetrics and Gynecology, School of Medicine International University of Health and Welfare Fukuoka Japan.
- Department of Obstetrics and Gynecology, Faculty of Medicine Toho University Tokyo Japan.
- Department of Obstetrics and Gynecology, Faculty of Medicine the University of Tokyo Tokyo Japan.
ORCID-Profile: Akira Iwase, Yoshikazu Kitahara, Hiromitsu Shirasawa, Michio Kitajima
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Iwase, A., Hasegawa, Y., Kitahara, Y., Jwa, S. C., Shirasawa, H., Kitajima, M., Katagiri, Y., Miyuki, H., Kazuhiro, K., & Osuka, S. (2026). Autoimmune Thyroid Disease and Female Fertility: Clinical Evidence on Ovarian Reserve, Infertility Treatment Outcomes, and Pathophysiology. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70052
Vancouver
Iwase A, Hasegawa Y, Kitahara Y, Jwa SC, Shirasawa H, Kitajima M, et al. Autoimmune Thyroid Disease and Female Fertility: Clinical Evidence on Ovarian Reserve, Infertility Treatment Outcomes, and Pathophysiology. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70052
BibTeX
@article{Iwase2026,
author = {Iwase, Akira and Hasegawa, Yuko and Kitahara, Yoshikazu and Jwa, Seung Chik and Shirasawa, Hiromitsu and Kitajima, Michio and Katagiri, Yukiko and Miyuki, Harada and Kazuhiro, Kawamura and Osuka, Satoko},
title = {Autoimmune Thyroid Disease and Female Fertility: Clinical Evidence on Ovarian Reserve, Infertility Treatment Outcomes, and Pathophysiology},
journal = {Reproductive Medicine and Biology},
year = {2026},
volume = {25},
number = {1},
doi = {10.1002/rmb2.70052}
}
EUVIMED